Literature DB >> 2492793

Inhibition of pyruvate carboxylase by sequestration of coenzyme A with sodium benzoate.

A D Griffith1, D M Cyr, S G Egan, G C Tremblay.   

Abstract

Pyruvate-dependent CO2 fixation by isolated mitochondria was strongly inhibited by sodium benzoate. Pyruvate carboxylase was identified as a site of inhibition by limiting flux measurements to assays of pyruvate carboxylase coupled with malate dehydrogenase. Benzoate reduced pyruvate-dependent incorporation of [14C]KHCO3 into malate and pyruvate-dependent malate accumulation by 74 and 72%, respectively. Aspartate-dependent malate accumulation was insensitive to benzoate, ruling out malate dehydrogenase as a site of action. Inhibition by benzoate was antagonized by glycine, which sharply accelerated conversion of benzoate to hippurate. Assays of coenzyme A and its acyl derivatives revealed inhibition to correlate with depletion of acetyl CoA and accumulation of benzoyl CoA. Depletion of acetyl CoA was sufficient to account for greater than 50% reduction in pyruvate carboxylase activity. Competition between acetyl CoA and benzoyl CoA for the activator site on pyruvate carboxylase was insignificant. Results support the interpretation that the observed inhibition of pyruvate carboxylase occurred primarily by depletion of the activator, acetyl CoA, through sequestration of coenzyme A during benzoate metabolism.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2492793     DOI: 10.1016/0003-9861(89)90101-x

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  8 in total

1.  Coenzyme A sequestration in rat hearts oxidizing ketone bodies.

Authors:  R R Russell; H Taegtmeyer
Journal:  J Clin Invest       Date:  1992-03       Impact factor: 14.808

2.  Normal rates of whole-body fat oxidation and gluconeogenesis after overnight fasting and moderate-intensity exercise in patients with medium-chain acyl-CoA dehydrogenase deficiency.

Authors:  Hidde H Huidekoper; Mariëtte T Ackermans; René Koopman; Luc J C van Loon; Hans P Sauerwein; Frits A Wijburg
Journal:  J Inherit Metab Dis       Date:  2012-09-14       Impact factor: 4.982

3.  Inhibitors of Pyruvate Carboxylase.

Authors:  Tonya N Zeczycki; Martin St Maurice; Paul V Attwood
Journal:  Open Enzym Inhib J       Date:  2010

4.  The influenza B virus mouse model of Reye's syndrome: pathogenesis of the hypoglycaemia.

Authors:  L E Davis; B M Woodfin; T Q Tran; L S Caskey; J M Wallace; O U Scremin; K S Blisard
Journal:  Int J Exp Pathol       Date:  1993-06       Impact factor: 1.925

Review 5.  Alternative pathway therapy for urea cycle disorders.

Authors:  F Feillet; J V Leonard
Journal:  J Inherit Metab Dis       Date:  1998       Impact factor: 4.982

6.  Dose-dependent pharmacokinetics of benzoic acid following oral administration of sodium benzoate to humans.

Authors:  K Kubota; T Ishizaki
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

Review 7.  Emergency management of inherited metabolic diseases.

Authors:  V Prietsch; M Lindner; J Zschocke; W L Nyhan; G F Hoffmann
Journal:  J Inherit Metab Dis       Date:  2002-11       Impact factor: 4.982

Review 8.  Suggested guidelines for the diagnosis and management of urea cycle disorders.

Authors:  Johannes Häberle; Nathalie Boddaert; Alberto Burlina; Anupam Chakrapani; Marjorie Dixon; Martina Huemer; Daniela Karall; Diego Martinelli; Pablo Sanjurjo Crespo; René Santer; Aude Servais; Vassili Valayannopoulos; Martin Lindner; Vicente Rubio; Carlo Dionisi-Vici
Journal:  Orphanet J Rare Dis       Date:  2012-05-29       Impact factor: 4.123

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.